Jan 12, 2022 / 08:45PM GMT
Anupam Rama - JPMorgan Chase & Co, Research Division - VP and Analyst
Welcome, everyone, to the 40th Annual JPMorgan Healthcare Conference. My name is Anupam Rama. I'm one of the senior biotech analysts here at JPMorgan, joined by Cable Smith, Malcolm Kuno and Priyanka Grover from the team. Our next presenting company is Amicus Therapeutics. And presenting on behalf of this company, we have CEO, John Crowley, and incoming CEO, Bradley Campbell. (Operator Instructions)
With that, John, Brad, take it away.
John F. Crowley - Amicus Therapeutics, Inc. - Chairman & CEO
Great. I'll go ahead and begin Anupam. Thank you, and thanks, everybody, for joining. This is going to be a very exciting year for Amicus as we're poised to launch our second medicine in the last several years for people living with rare diseases. So we'll come to that on the first slide here, I'll just reference that Bradley, and I will be making forward-looking statements. And then on the next slide, if we fast forward to Slide 4, you'll see a snapshot of Amicus and who we are today.
Amicus Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Feb 07, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers